Novo Nordisk says it is gradually phasing out human insulin pens globally
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Fortune8 个月
The Goulet Pen Company
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
Business Insider10 天
Penumbra (PEN) Receives a Buy from BTIG
BTIG analyst Ryan Zimmerman maintained a Buy rating on Penumbra (PEN – Research Report) yesterday and set a price target of $232.00. The company’s shares closed yesterday at $229.51. Zimmerman covers ...
Truist Financial Sticks to Their Buy Rating for Penumbra (PEN)
Truist Financial analyst Richard Newitter maintained a Buy rating on Penumbra (PEN – Research Report) yesterday and set a price target of ...